Skip to content

Endometrial Advancement After Rec or u-HCG Triggering

Endometrial Advancement After Rec or u-HCG Triggering

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00953628
Enrollment
130
Registered
2009-08-06
Start date
2005-08-31
Completion date
2008-12-31
Last updated
2015-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

endometrium, histology, pregnancy

Brief summary

The purpose of this study is to investigate any potential advantages of replacing human chorionic gonadotropin (uhCG) with recombinant human chorionic gonadotropin (recHCG) for final oocyte maturation with regard to Ovarian hyperstimulation syndrome (OHSS)pathophysiology, endometrium receptivity and embryo quality and clinical pregnancy.

Detailed description

Biopsies of endometrium were taken in different groups Pregnancy rates were compared among defferent groups

Interventions

bolus 10000 units for ovulation triggering

bolus 250 mcg for ovulation triggering in IVF patients

Sponsors

Merck Serono International SA
CollaboratorINDUSTRY
Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 36 Years
Healthy volunteers
No

Inclusion criteria

* Less than 36 years old * Male or tubal infertility * FSH\<12 on day 3

Exclusion criteria

* Endometriosis stage 3 & 4

Design outcomes

Primary

MeasureTime frame
endometrium histology on the day of OPUday of oocytre pick up

Secondary

MeasureTime frame
pregnancy rate14 days after oocyte pick up

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026